Life sciences M&A value of portfolio optimization worldwide by therapeutic area 2020
Oncology was the therapeutic area with the largest potential in M&A value of protfolio optimization, as of early 2020. The potential deal multiplier stood at six, with a potential asset value of 84 billion U.S. dollars. This statistic illustrates the life sciences M&A value of portfolio optimization worldwide as of 2020, by five selected therapeutic areas.